StockData
Health Catalyst, Inc. logo

Health Catalyst, Inc. (HCAT) stock

HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)

Close on Nov 17, 2026Market cap $103.10MP/E –Yield –

Earnings

Health Catalyst's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$56.28M
-26.3% on a year earlier
Adjusted Net Income (Loss) per share, basic and diluted, Q3 FY2026
-$0.03
$0.06 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Health Catalyst's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$56.28M-26.3%$0.53-$0.03Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close––––Release
Q1 FY2026ended Mar 31, 2026May 11, 2026after the close––––Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026after the close$74.68M–-$1.28$0.08Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025after the close$76.32M–-$0.32$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$80.72M–-$0.59$0.04Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close––––Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025after the close––––Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024after the close––––Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close––-$0.23$0.12Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$0.35$0.05Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Health Catalyst's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenueGAAPFY2026$246.00M – $249.00M–NewNov 5, 2026
Total revenueGAAPFY2026$246.00M – $249.00M$260.00M – $265.00MLoweredAug 6, 2026
Adjusted EBITDAnon-GAAPFY2026$18.00M – $18.50M–NewNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$18.00M – $18.50M$30.00M – $33.00MLoweredAug 6, 2026

Guidance vs results

The last range Health Catalyst gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$55.00M – $56.00M$56.28MAbove range
Q4 FY2025Revenue$73.50M$74.68MAbove range
Q3 FY2025Revenue$75.00M$76.32MAbove range
Q2 FY2025Revenue$80.50M$80.72MAbove range
Q4 FY2023Revenue$70.10M – $75.10M$75.08MWithin range
Q3 FY2023Revenue$70.20M – $74.20M$73.77MWithin range
Q2 FY2023Revenue$70.30M – $74.30M$73.21MWithin range
Q1 FY2023Revenue$70.30M – $72.30M$73.87MAbove range
Q4 FY2022Revenue$66.90M – $68.90M$69.16MAbove range
Q3 FY2022Revenue$65.30M – $68.30M$68.35MAbove range
Q2 FY2022Revenue$68.00M – $71.00M$70.63MWithin range
Q1 FY2022Revenue$64.00M – $67.00M$68.09MAbove range

Guidance history

Every forecast Health Catalyst put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$18.00M – $18.50MNew
Nov 5, 2026Total revenueFY2026$246.00M – $249.00MNew
Aug 6, 2026Adjusted EBITDAFY2026$18.00M – $18.50MLowered
Aug 6, 2026Adjusted EBITDAQ3 FY2026$0 – $500.00KNew
Aug 6, 2026Total revenueFY2026$246.00M – $249.00MLowered
Aug 6, 2026Total revenueQ3 FY2026$55.00M – $56.00MNew
May 11, 2026Adjusted EBITDAFY2026$30.00M – $33.00MNew
May 11, 2026Adjusted EBITDAQ2 FY2026$9.00M – $10.00MNew
May 11, 2026Total revenueFY2026$260.00M – $265.00MNew
May 11, 2026Total revenueQ2 FY2026$68.00M – $70.00MNew
Mar 12, 2026Adjusted EBITDAQ1 FY2026$7.00M – $8.00MNew
Mar 12, 2026Total revenueQ1 FY2026$68.00M – $70.00MNew
Nov 10, 2025Adjusted EBITDAFY2025$41.00MNew
Nov 10, 2025Adjusted EBITDAQ4 FY2025$13.40MNew
Nov 10, 2025Total revenueFY2025$310.00MNew
Nov 10, 2025Total revenueQ4 FY2025$73.50MNew
Aug 7, 2025Adjusted EBITDAQ3 FY2025$10.50MNew
Aug 7, 2025Adjusted EBITDAFY2025$41.00MReaffirmed
Aug 7, 2025Total revenueQ3 FY2025$75.00MNew
Aug 7, 2025Total revenueFY2025$310.00MLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Health Catalyst filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Results
  5. Results
  6. Results
  7. Update
  8. Results
  9. Update
  10. Results
  11. Update
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?